Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

3.5K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.5K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

442
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
442
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

3.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unsupervised Estimation of Monocular Depth and VO in Dynamic Environments via Hybrid Masks.

IEEE transactions on neural networks and learning systems·2021
Same author

β-Caryophyllene attenuates lipopolysaccharide-induced acute lung injury via inhibition of the MAPK signalling pathway.

The Journal of pharmacy and pharmacology·2021
Same author

Robotic Gastrectomy Versus Laparoscopic Gastrectomy for Gastric Cancer: A Multicenter Cohort Study of 5402 Patients in China.

Annals of surgery·2021
Same author

Allergen-Specific Treg Cells Upregulated by Lung-Stage <i>S. japonicum</i> Infection Alleviates Allergic Airway Inflammation.

Frontiers in cell and developmental biology·2021
Same author

Dhx15 regulates zebrafish definitive hematopoiesis through the unfolded protein response pathway.

Cancer science·2021
Same author

IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells <i>via</i> Aryl Hydrocarbon Receptor Activation.

Frontiers in immunology·2021

Related Experiment Video

Updated: Jan 16, 2026

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

9.8K

Targeting Focal Adhesion Kinase in Lung Diseases: Current Progress and Future Directions.

Ziyu Wan1, Zefeng Zhu1, Pengbin Wang1

  • 1Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Department of Biochemistry and Molecular Biology, Bengbu Medical University, Bengbu 233030, China.

Biomolecules
|September 27, 2025
PubMed
Summary

Focal adhesion kinase (FAK) inhibitors show promise for treating lung diseases like cancer, acute lung injury, and fibrosis by blocking key signaling pathways. Further clinical studies are needed to confirm their efficacy and safety.

Keywords:
ALIFAKFAK inhibitorsbronchial asthmalung cancerpulmonary fibrosis

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.6K
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.4K

Related Experiment Videos

Last Updated: Jan 16, 2026

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

9.8K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.6K
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.4K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology
  • Pulmonology

Background:

  • Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase vital for cell adhesion and migration.
  • FAK is overexpressed in various cancers and implicated in lung diseases like acute lung injury (ALI) and pulmonary fibrosis (PF).

Purpose of the Study:

  • To review recent advancements in FAK inhibitors for treating pulmonary diseases.
  • To discuss the therapeutic potential and underlying mechanisms of FAK inhibition in lung conditions.

Main Methods:

  • Literature review of studies from 2015 to present.
  • Analysis of FAK structure, function, and inhibitor effects in preclinical models.

Main Results:

  • FAK inhibitors exhibit anti-tumor, anti-inflammatory, and anti-fibrotic effects in lung cancer, ALI, and PF models.
  • Preclinical studies show promising efficacy and safety, with several inhibitors in clinical trials.

Conclusions:

  • Targeting FAK presents a novel therapeutic strategy for diverse lung diseases.
  • Further clinical validation and mechanistic investigations are essential for FAK inhibitor development.